44|María Cascales
2.
Alsasua del Valle, A ( (2013) Sobrepeso y Obesidad. VII Jornada Científica. Beresit. Toledo
pp 11-‐23.
3.
Latili G, Gallo F y Lugheti L (2010) Toxic environment and obesity pandemia: Is there a
relationship? Ital J Pediatr. 36, 8.
4.
Bleich S, Cutler D, Murray C, Adams A (2008). Why is the developed world obese?. Annu
Rev Public Health 29, 273–95.
5.
Brahe LK, Astrup A, Larsen LH (2013) Is butyrate the link between diet, intestinal
microbiota and obesity-‐related metabolic diseases? Obes Rev 14, 950-‐959.
6.
Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab. 89, 2583-‐2589.
7.
Cascales M, Sánchez-‐Muniz F y Ribas B (2014) La Obesidad: Una pandemia de nuestro
tiempo. En Primer curso Avanzado sobre Obesidad (eds Cascales M, Sánchez.Muniz P y
Ribas B) Monografía 38 Real Acadmic Nacional de Farmacia. pp 28-‐48 Madrid.
8.
Chechi K, Nedergaard J, Richard D (2014) Brown adipose tissue as an anti-‐obesity tissue in
humans. Obes Rev 15, 92-‐106.
9.
Costa-‐Font J y Mas N (2014) 'Globesity'? The Effects of Globalization on Obesity and Caloric
IntakeCESifo Working Paper Series No. 4982.
10.
Dentali F, Squizzato A, Ageno W (2009). The metabolic syndrome as a risk factor for
venous and arterial thrombosis. Semin. Thromb. Hemost. 35, 451-‐ 457.
11.
Escobedo G, López-‐Ortiz E, Torres-‐Castro I (2009) La microbiota como agente inductor de
la obesidad, la inflamación sistémica y la resistencia a la insulina. Acta Pediatr Esp. 67,
437-‐442.
12.
Fernández-‐Veledo S (2010) Obesidad, inflamación y resistencia a la insulina. SEBBM,
divulgación Noviembre 2010. Homenaje a Margarita Lorenzo.
13.
Frayling TM, Timpson NJ, Weedon MN, et al (2007). A common variant in the FTO gene is
associated with body mass index and predisposes to childhood and adult obesity. Science
316, 889-‐894.
14.
Grün F. Blumberg B. (2009) Endocrine disrupters as obesogens Mol Cell Endocrinol. 304,
19–29.
15.
Grundy SM (2004). Obesity, metabolic syndrome, and cardiovascular disease. J. Clin.
Endocrinol. Metab. 89, 2595-‐2600.
16.
Hanson MA, Gluckman PD(2008) Developmental origins of health and disease: new
insights. Basic Clin Pharmacol Toxicol. 102, 90–93.
17.
Harris K,
Kassis A, Major G y Chou CJ (2012) Is the GutMicrobiota a New Factor
Contributing to Obesity and ItsMetabolic Disorders? Journal of Obesity. Volume 2012,
Article ID 879151, 14 pages Hindawi Publishing Corporation
18.
Haslam DW, James WP (2005). Obesity. Lancet 366, 1197-‐1209.
19.
Heindel JJ y vom Saal FS (2009) Role of nutrition and environmental endocrine disrupting
chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol. 304,
90–96.
